Updates are available Correction dated 2017-09-12
Click to view Correction: https://doi.org/10.1038/nrclinonc.2017.86
-
Authors
Ahmed, Hashim U.
,
Berge, Viktor
Bottomley, David
Cross, William
Heer, Rakesh
Kaplan, Richard
Leslie, Tom
Parker, Chris
Relton, Clare
Stephens, Richard
Sydes, Matthew R.
Turnbull, Lindsay
van der Meulen, Jan
Vickers, Andrew
Wilt, Timothy
Emberton, Mark
- License Information
-
More Information
Article History
First Online: 22 April 2014
Change Date: 12 September 2017
Change Type: Correction
Change Details: Nature Reviews Clinical Oncology 11, 482–491 (2014) In the published version of this article, the affiliation and position held by Dr Viktor Berge was incorrectly stated as Professor of Urology and Director of Research at the University Hospital Oslo. Dr Berge is a Consultant Urologist at the Department of Urology, at the Oslo University Hospital.
Competing interests
: H.U.A. has received research funding from the following companies: Advanced Medical Diagnostics, GlaxoSmithKline and Sonacare. M.E. has received research funding from the following companies: Advanced Medical Diagnostics, GlaxoSmithKline, Steba Biotech and Sonacare. M.E. is a paid consultant for GlaxoSmithKline, Steba Biotech and Sonacare. M.E. is a director on the board of and has share options in Nuada Medical. The other authors declare no competing interests.
